Stock Price
38.99
Daily Change
0.76 1.99%
Monthly
-0.03%
Yearly
-18.45%
Q3 Forecast
37.22

EPS Reference Time Actual Consensus Previous
2026-11-05 FY2026Q4 AM 0.69 0.68
2026-07-31 FY2026Q3 AM 0.70 0.56 0.64
2026-05-07 FY2026Q2 AM 0.53 0.52 0.56
2026-02-05 FY2026Q1 AM 0.49 0.45 0.51
2025-11-05 FY2025Q4 AM 0.68 0.71 0.67



Peers Price Chg Day Year Date
Brookdale Senior Living 12.09 -0.05 -0.41% 61.42% Sep/14
Cencora 326.23 4.66 1.45% 11.95% Sep/14
Encompass Health 122.78 1.07 0.88% -1.51% Sep/14
Enovis 18.26 -1.02 -5.29% -43.54% Sep/14
GE HealthCare Technologies 64.26 0.33 0.52% -17.36% Sep/14
Pediatrix Medical Group 26.89 0.12 0.45% 25.24% Sep/14
Veradigm 4.89 0.29 6.30% 5.16% Sep/14
OPKO Health 478.90 19.90 4.34% 3.41% Sep/14
Siemens Healthineers 38.99 0.76 1.99% -18.45% Sep/14
Zimmer Biomet Holdings 96.11 2.62 2.80% -4.80% Sep/14

Indexes Price Day Year Date
DE40 25441 -127.75 -0.50% 7.12% Sep/14

Siemens Healthineers AG traded at 38.99 this Monday September 14th, increasing 0.76 or 1.99 percent since the previous trading session. Looking back, over the last four weeks, Siemens Healthineers gained 0.03 percent. Over the last 12 months, its price fell by 18.45 percent. Looking ahead, we forecast Siemens Healthineers AG to be priced at 37.22 by the end of this quarter and at 34.36 in one year, according to Trading Economics global macro models projections and analysts expectations.

Siemens Healthineers AG is a Germany-based company. The Company is a global provider of healthcare products, solutions and services. It also provides clinical consulting services and training and service offerings. The Company’s segments include Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers a software solutions to support the reading and structured reporting of diagnostic images from different modalities. The Diagnostics segment offers to healthcare providers in the fields of general laboratory, specialty laboratory, and point-of-care diagnostics. The Varian segment offers a portfolio of cancer care technologies and services and support oncology departments in hospitals and clinics. The Advanced Therapies segment consists of integrated products, services and solutions used in the treatment of diseases across multiple clinical fields.